Skip to main content

Table 1 List of cancer datasets used in this analysis

From: E2F4 regulatory program predicts patient survival prognosis in breast cancer

GSE ID Platform Cancer type Number of samples Source
- cDNA two channel Breast 295 Vijver et al., 2002 [4]
GSE1456 HG-U133A Breast 159 Pawitan et al., 2005 [8]
GSE2034 HG-U133A Breast 286 Wang et al., 2005 [5]
GSE2990 HG-U133A Breast 177 Sotiriou et al., 2006 [6]
GSE3494 HG-U133A Breast 260 Miller et al., 2005 [7]
GSE6532 HG-U133A Breast 327 Loi et al., 2008 [33]
GSE7390 HG-U133A Breast 198 Desmedt et al., 2007 [34]
GSE11121 HG-U133A Breast 200 Schmidt et al., 2008 [35]
GSE13507 Illumina beadchip Bladder 256 Kim et al., 2010 [36]
GSE13041 HG-U133A Glioblastoma 191 Lee et al., 2008 [37]
GSE8894 HG-U133 Plus 2 Non-small cell lung 138 Lee et al., 2008 [38]
GSE17536 HG-U133 Plus 2 Colon 177 Smith et al., 2010 [39]
GSE425 cDNA two channel Acute myeloid leukemia 119 Bullinger et al., 2004 [40]
GSE4475 HG-U133A Burkitt’s lymphoma 221 Hummel et al., 2006 [41]